Attenuation of collagen-induced arthritis in rat by nicotinic Alpha7 receptor partial agonist GTS-21

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Hu, Yiping ^a   Liu, Ruoxi ^b   Li, Jinchao ^a   Yue, Ye ^a   Cheng, Wenxiang ^a   Zhang, Peng ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; EOSIN; HEMATOXYLIN; INTERLEUKIN 1; INTERLEUKIN 6; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA; 3-(2,4-DIMETHOXYBENZYLIDENE)ANABASEINE; BENZYLIDENE DERIVATIVE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE DEFECT; CARTILAGE DEGENERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOLOGY; MALE; NONHUMAN; RAT; SCORING SYSTEM; STAINING; ANIMAL; ARTHRITIS, EXPERIMENTAL; BLOOD; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BENZYLIDENE COMPOUNDS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RECEPTORS, NICOTINIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897842984     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/325875     Document Type: Article

References (49)

1. Scott D. L., Wolfe F., Huizinga T. W. J., Rheumatoid arthritis. The Lancet 2010 376 9746 1094 1108 2-s2.0-77957196913 10.1016/S0140-6736(10)60826-4
2. Caporali R., Cavagna L., Montecucco C., Pain in arthritis. European Journal of Pain Supplements 2009 3 2 123 127 2-s2.0-70350782326 10.1016/j.eujps.2009.07.009
3. Fautrel B., Gaujoux-Viala C., Medical and economic aspects of rheumatoid arthritis. Bulletin de l'Academie Nationale de Medecine 2010 196 7 1295 1305
4. Ogdie A., Haynes K., Troxel A. B., Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Annals of the Rheumatic Diseases 2014 73 1 149 153 10.1136/annrheumdis- 2012-202424
5. Meune C., Touzé E., Trinquart L., Allanore Y., High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Archives of Cardiovascular Diseases 2010 103 4 253 261 2-s2.0-77954863939 10.1016/j.acvd.2010.03.007
6. Cavagna L., Monti S., Grosso V., The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. BioMed Research International 2013 2013 13 759760 10.1155/2013/759760
7. Cavagna L., Boffini N., Cagnotto G., Inverardi F., Grosso V., Caporali R., Atherosclerosis and rheumatoid arthritis: more than a simple association. Mediators of Inflammation 2012 2013 8 147354 10.1155/2012/147354
8. Zhang P., Han D., Tang T., Zhang X., Dai K., Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflammation Research 2008 57 7 322 328 2-s2.0-51849148885 10.1007/s00011-008-8070-1
9. Kokkola R., Li J., Sundberg E., Aveberger A.-C., Palmblad K., Yang H., Tracey K. J., Andersson U., Erlandsson Harris H., Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis and Rheumatism 2003 48 7 2052 2058 2-s2.0-0038681182 10.1002/art.11161 (Pubitemid 36828701)
10. Bresnihan B., Alvaro-Gracia J. M., Cobby M., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis and Rheumatism 1998 41 12 2196 2204 (Pubitemid 29009378)
11. Åkerlund K., Erlandsson Harris H., Tracey K. J., Wang H., Fehniger T., Klareskog L., Andersson J., Andersson U., Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF- α) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clinical and Experimental Immunology 1999 115 1 32 41 2-s2.0-0032946392 10.1046/j.1365-2249.1999.00750.x (Pubitemid 29030361)
12. Sakellariou G., Scire C. A., Verstappen S. M., Montecucco C., Caporali R., In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis. Annals of the Rheumatic Diseases 2013 72 2 245 249 10.1136/annrheumdis-2012-201817
13. Gremese E., Salaffi F., Bosello S. L., Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Annals of the Rheumatic Diseases 2013 72 6 858 862 10.1136/annrheumdis-2012-201456
14. Smolen J. S., Landewe R., Breedveld F. C., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases 2013 10.1136/annrheumdis-2013-204573
15. Blüml S., Scheinecker C., Smolen J. S., Redlich K., Targeting TNF receptors in rheumatoid arthritis. International Immunology 2012 24 5 275 281 2-s2.0-84859967424 10.1093/intimm/dxs047
16. Bagust A., Boland A., Hockenhull J., Fleeman N., Greenhalgh J., Dundar Y., Proudlove C., Kennedy T., Moots R., Williamson P., Dickson R., Rituximab for the treatment of rheumatoid arthritis. Health Technology Assessment 2009 13 supplement 2 23 29 2-s2.0-75649113848
17. Md Yusof M. Y., Emery P., Targeting interleukin-6 in rheumatoid arthritis. Drugs 2013 73 4 341 356 10.1007/s40265-013-0018-2
18. Emery P., The therapeutic potential of costimulatory blockade with CTLA4lg in rheumatoid arthritis. Expert Opinion on Investigational Drugs 2003 12 4 673 681 2-s2.0-0037399411 10.1517/13543784.12.4.673 (Pubitemid 36512011)
19. Sarzi-Puttini P., Antivalle M., Marchesoni A., Favalli E. G., Gorla R., Filippini M., Caporali R., Bobbio-Pallavicini F., Montecucco C., Atzeni F., Efficacy and safety of anti-TNF agents in the Lombardy Rheumatoid Arthritis Network (LORHEN). Reumatismo 2008 60 4 290 295 2-s2.0-61549086004
20. Atzeni F., Sarzi-Puttini P., Mutti A., Bugatti S., Cavagna L., Caporali R., Long-term safety of abatacept in patients with rheumatoid arthritis. Autoimmunity Reviews 2013 12 12 1115 1117
21. Atzeni F., Bongiovanni S., Marchesoni A., Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. Joint Bone Spine 2013 10.1016/j.jbspin.2013.04.005
22. Quartuccio L., Fabris M., Pontarini E., The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. Annals of the Rheumatic Diseases 2013 10.1136/annrheumdis-2012-202435
23. Burmester G. R., Feist E., Dorner T., Emerging cell and cytokine targets in rheumatoid arthritis. Nature Reviews 2013 10.1038/nrrheum.2013.168
24. Ulloa L., The vagus nerve and the nicotinic anti-inflammatory pathway. Nature Reviews Drug Discovery 2005 4 8 673 684 2-s2.0-23844517664 10.1038/nrd1797 (Pubitemid 41149761)
25. Van Maanen M. A., Lebre M. C., Van Der Poll T., LaRosa G. J., Elbaum D., Vervoordeldonk M. J., Tak P. P., Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis and Rheumatism 2009 60 1 114 122 2-s2.0-58249121600 10.1002/art.24177
26. Oke S. L., Tracey K. J., The inflammatory reflex and the role of complementary and alternative medical therapies. Annals of the New York Academy of Sciences 2009 1172 172 180 2-s2.0-69549126289 10.1196/annals.1393.013
27. Kem W. R., Mahnir V. M., Prokai L., Papke R. L., Cao X., LeFrancois S., Wildeboer K., Prokai-Tatrai K., Porter-Papke J., Soti F., Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration. Molecular Pharmacology 2004 65 1 56 67 2-s2.0-9144251593 10.1124/mol.65.1.56 (Pubitemid 38113886)
28. Westman M., Engström M., Catrina A. I., Lampa J., Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scandinavian Journal of Immunology 2009 70 2 136 140 2-s2.0-67651246901 10.1111/j.1365-3083.2009.02266.x
29. van Westerloo D. J., Giebelen I. A., Florquin S., Bruno M. J., LaRosa G. J., Ulloa L., Tracey K. J., van der Poll T., The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006 130 6 1822 1830 2-s2.0-33646522174 10.1053/j.gastro.2006.02.022
30. Pavlov V. A., Ochani M., Yang L.-H., Gallowitsch-Puerta M., Ochani K., Lin X., Levi J., Parrish W. R., Rosas-Ballina M., Czura C. J., LaRosa G. J., Miller E. J., Tracey K. J., Al-Abed Y., Selective α 7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Critical Care Medicine 2007 35 4 1139 1144 2-s2.0-34247125289 10.1097/01.CCM.0000259381.56526.96 (Pubitemid 46598966)
31. Giebelen I. A. J., Van Westerloo D. J., LaRosa G. J., De Vos A. F., Van Der Poll T., Local stimulation of α 7 cholinergic receptors inhibits LPS-induced TNF- α release in the mouse lung. Shock 2007 28 6 700 703 2-s2.0-36249019691 10.1097/shk.0b013e318054dd89 (Pubitemid 350135475)
32. Su X., Jae W. L., Matthay Z. A., Mednick G., Uchida T., Fang X., Gupta N., Matthay M. A., Activation of the α 7 nAChR reduces acid-induced acute lung injury in mice and rats. American Journal of Respiratory Cell and Molecular Biology 2007 37 2 186 192 2-s2.0-34547867437 10.1165/rcmb.2006-0240OC (Pubitemid 47255001)
33. Kox M., van Velzen J. F., Pompe J. C., Hoedemaekers C. W., van der Hoeven J. G., Pickkers P., GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochemical Pharmacology 2009 78 7 863 872 2-s2.0-68349160714 10.1016/j.bcp.2009.06.096
34. Giebelen I. A. J., Van Westerloo D. J., LaRosa G. J., De Vos A. F., Van Der Poll T., Stimulation of α 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor α -independent mechanism. Shock 2007 27 4 443 447 2-s2.0-34247101624 10.1097/01.shk.0000245016.78493.bb (Pubitemid 46594978)
35. Rosas-Ballina M., Goldstein R. S., Gallowitsch-Puerta M., Yang L., Valdés-Ferrer S. I., Patel N. B., Chavan S., Al-Abed Y., Yang H., Tracey K. J., The selective α 7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Molecular Medicine 2009 15 7-8 195 202 2-s2.0-67650391166 10.2119/molmed.2009.00039
36. Holmdahl R., Andersson M. E., Goldschmidt T. J., Jansson L., Karlsson M., Malmstrom V., Mo J., Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 1989 97 7 575 584 2-s2.0-0024338671 (Pubitemid 19188331)
37. Trentham D. E., Townes A. S., Kang A. H., Autoimmunity to type II collagen: an experimental model of arthritis. Journal of Experimental Medicine 1977 146 3 857 868 2-s2.0-0017657009 (Pubitemid 8175993)
38. van Holten J., Reedquist K., Sattonet-Roche P., Smeets T. J. M., Plater-Zyberk C., Vervoordeldonk M. J., Tak P. P., Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Research & Therapy 2004 6 3 R239 R249 2-s2.0-17644372231
39. Lin H.-S., Hu C.-Y., Chan H.-Y., Liew Y.-Y., Huang H.-P., Lepescheux L., Bastianelli E., Baron R., Rawadi G., Clément-Lacroix P., Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. British Journal of Pharmacology 2007 150 7 862 872 2-s2.0-34047210698 10.1038/sj.bjp.0707165 (Pubitemid 46536628)
40. Tomita T., Takeuchi E., Tomita N., Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis and Rheumatism 1999 42 12 2532 2542 (Pubitemid 30327169)
41. Schett G., Stolina M., Dwyer D., Zack D., Uderhardt S., Kronke G., Kostenuik P., Feige U., Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. Arthritis and Rheumatism 2009 60 9 2644 2654 2-s2.0-69449086400 10.1002/art.24767
42. Kawashima K., Fujii T., Moriwaki Y., Misawa H., Horiguchi K., Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function. Annals of the New York Academy of Sciences 1261 7 17
43. Pohanka M., Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. International Journal of Molecular Sciences 2012 13 2 2219 2238 2-s2.0-84857663983 10.3390/ijms13022219
44. Cai B., Chen F., Ji Y., Kiss L., de Jonge W. J., Conejero-Goldberg C., Szabo C., Deitch E. A., Ulloa L., Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. Journal of Cellular and Molecular Medicine 2009 13 9 3774 3785 2-s2.0-77449083458 10.1111/j.1582-4934. 2008.00550.x
45. Nanri M., Kasahara N., Yamamoto J., Miyake H., Watanabe H., A comparative study on the effects of nicotine and GTS-21, a new nicotinic agonist, on the locomotor activity and brain monoamine level. Japanese Journal of Pharmacology 1998 78 3 385 389 2-s2.0-0031790269 10.1254/jjp.78.385 (Pubitemid 28554207)
46. Meyer E. M., Kuryatov A., Gerzanich V., Lindstrom J., Papke R. L., Analysis of 3-(4-hydroxy, 2-methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics 1998 287 3 918 925 2-s2.0-0032254325 (Pubitemid 29131601)
47. Conejero-Goldberg C., Davies P., Ulloa L., Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neuroscience and Biobehavioral Reviews 2008 32 4 693 706 2-s2.0-40149104224 10.1016/j.neubiorev. 2007.10.007
48. Ochi S., Shinohara M., Sato K., Gober H.-J., Koga T., Kodama T., Takai T., Miyasaka N., Takayanagi H., Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proceedings of the National Academy of Sciences of the United States of America 2007 104 27 11394 11399 2-s2.0-34547470906 10.1073/pnas.0701971104 (Pubitemid 47175151)
49. Geboes L., De Klerck B., Van Balen M., Kelchtermans H., Mitera T., Boon L., De Wolf-Peeters C., Matthys P., Freund's complete adjuvant induces arthritis in mice lacking a functional interferon- γ receptor by triggering tumor necrosis factor α -driven osteoclastogenesis. Arthritis and Rheumatism 2007 56 8 2595 2607 2-s2.0-34547772582 10.1002/art.22791 (Pubitemid 47237278)